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ABSTRACT
Background: Although procaterol is used clinically as a β2-adrenergic receptor agonist to relax airway smooth
muscle, it has not yet been clarified whether procaterol has inotropic effects on respiratory muscles.
Methods: Three intervention groups were investigated: a procaterol inhalation only group; a procaterol inhala-
tion plus endotoxin injection group (in vivo); and a procaterol incubation group (in vitro). The diaphragm muscle
in all groups was dissected and measurements of its contractile properties were performed.
Results: The effects of procaterol inhalation shifted the force-frequency curves upward at 30 minutes after in-
halation, and inhibited the decline of force-frequency curves due to endotoxin injection in vivo. In vitro admini-
stration of procaterol resulted in an increase in the force-frequency curves in a dose-dependent manner.
Conclusions: It can be concluded that procaterol has an inotropic effect on the diaphragmatic muscles taken
from normal animals as well as on the diaphragm muscles in a septic animal model.
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INTRODUCTION
Procaterol is used clinically as a β2-adrenergic recep-
tor agonist (β2-agonist) to relax airway smooth mus-
cle and is a principal bronchodilator agent used to
treat bronchial asthma by metered dose inhalation
(MDI). Procaterol, salbutamol and tulobuterol are
classified as short-acting β2-agonists, and formoterol
and salmeterol are long-acting β2-agonists. The rank
order of relaxation efficacy of these β2-agonists seems
to be as follows: isoproterenol = procaterol = for-
moterol > salbutamol > salmeterol >> tulobuterol.1
Therefore, procaterol is classified as a selective full or
strong β2-adrenergic receptor agonist. Based on
these relationships, bronchodilators are used to treat
patients with bronchial asthma. Following a previous
report showing that isoproterenol stimulates cAMP
synthesis via β2-adrenergic receptor in the skeletal
muscle,2 there have been several reports concerning
the effects of β2-agonists on the diaphragm muscle,
namely, isoproterenol and aminophylline were shown
to improve the contractility of fatigued canine dia-
phragms.3 In addition, fenoterol improved fatigued
canine diaphragms,4 terbutaline activated contraction
in isolated fast- and slow-twitch skeletal muscle fi-
bers in rats,5 and broxaterol increased the force out-
put of fatigued canine diaphragm more than salbuta-
mol.6 From these reports, it seems likely that β2-
agonists increase contractility in normal and fatigued
diaphragm muscles. However, it has not yet been
clarified whether procaterol has inotropic effects on
respiratory muscles, especially on diaphragm mus-
cles.
In addition, it is known that the injection of endo-
toxin induces a decrement in diaphragm muscle con-
tractility and that this deterioration may be caused by
a network of cytokines such as tumor necrosis factor-
α (TNF-α) and free radicals such as nitric oxide (NO)
and oxygen derived intermediates, including super-
oxide and the hydroxyl radical.7,8 We have recently
reported that IL-109 and IL-1310 play a protective role
in diaphragm muscle after endotoxin injection into
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the peritoneal cavity. Because it has been reported
that isoproterenol has protective effects on diaphrag-
matic contractility in septic peritonitis,11 it is sug-
gested that procaterol could prevent endotoxin-
induced diaphragm muscle deterioration.
Accordingly, we first attempted to examine the ef-
fects of procaterol inhalation in normal animals and
measured the diaphragm contractile properties. Sec-
ondly, we examined whether procaterol exerted any
protective effects against endotoxin induced deterio-
ration. Thirdly, to ascertain whether procaterol has
any direct effects on diaphragm muscles, we incu-
bated diaphragm muscle strips in three different con-
centrations of procaterol in vitro. We found that pro-
caterol increases contraction in normal and endotoxin
damaged diaphragm muscles (in vivo study) and in-
creases the force-frequency curves in a dose-
dependent manner (in vitro study).
METHODS
ANIMAL PREPARATION
Experiments were performed on 95 animals divided
into three groups using BALBc mice weighing
23.1 ± 0.4 g (Charles River Japan, Yokohama, Japan).
(A) In the procaterol inhalation group, animals were
given 2 inhalation puffs from a procaterol MDI (me-
tered dose inhaler) via a 75-ml spacer, and then dia-
phragm muscles were dissected and the contractility
was measured immediately (0 hours), 30 minutes, 1
hour, 2 hours and 4 hours later (n = 5 animals each).
(B) In the endotoxin only groups, animals were given
an intraperitoneal injection of E. coli endotoxin (20
mgkg, 055: B5, Sigma Chemical Co., St. Louis, MO,
USA) in 0.5 ml of saline, with measurement of mus-
cle contractility immediately (0 hours), 2 hours and 4
hours later (n = 5 animals each). In the procaterol in-
halation plus endotoxin groups, animals were initially
given 2 puffs of inhalation from a procaterol MDI via
a 75-ml spacer, followed 5 minutes later by an intrape-
ritoneal injection of E. coli endotoxin (20 mgkg) in
0.5 ml of saline. The diaphragm muscles were then
dissected and measured as to muscle contractility im-
mediately (0 hours), 2 hours and 4 hours later (n = 5
animals each). Because we previously showed that
the force-frequency curves decreased maximally at 3―
4 hours and then recovered at 6 hours after endo-
toxin injection,8 we measured and analyzed dia-
phragm muscle contractility at 4 hours after endo-
toxin administration. (C) In the in vitro groups, dia-
phragm muscles taken from normal animals (n = 5
animals each) and other diaphragm muscles taken at
4 hours after intraperitoneal injection of E. coli endo-
toxin (20 mgkg) in 0.5 ml of saline (n = 5 animals
each) were incubated in an organ buffer with concen-
trations of 0, 10−5, 10−6, and 10−7 M of procaterol hy-
drochloride (Sigma Chemical Co.) for 1 hour each,
and then their respective contractile properties were
measured. Written approval was obtained from the
Tohoku University Animal Facility.
MEASUREMENTS OF MUSCLE CONTRACTION
Muscle strips (width; 3―4 mm, length; 8―11 mm,
weight; 0.008―0.010 g ) were dissected from the right
and left hemidiaphragm of each animal under diethyl
ether anesthesia and mounted in separate organ
baths containing Krebs-Henseleit solution oxygen-
ated with a 95% O2 −5% CO2 gas mixture (37.0 ±
0.5℃, pH 7.40 ± 0.05). The composition of the aerated
Krebs-Henseleit solution in mEqL was as follows:
Na+, 153.8; K+, 5.0; Ca2+, 5.0; Mg2+, 2.0; Cl−, 145.0;
HCO3−, 15.0; HPO42−, 1.9; SO42−, 2.0; glucose, 110
mg%; d-tubocurarine, 10 μM; and regular crystalline
zinc insulin, 50 Uliter. Both muscle strips were si-
multaneously stimulated with supramaximal currents
of 200―250 mA (i.e., 1.2 to 1.5 times the current re-
quired to elicit maximal twitch tension, pulse dura-
tion of 0.2 ms) by a constant current stimulus isola-
tion unit (SS-302J, Nihon Kohden Co., Tokyo, Japan)
driven by a stimulator (SEN-3201, Nihon Kohden
Co.). The elicited tensions were measured by a force
transducer (UL-100GR, Minebea Co., Fujisawa, Ja-
pan). The length of each muscle strip was changed
by moving the position of the force transducer with a
micrometer-controlled rack and pinion gear (accu-
racy of displacement, 0.05 mm; Mitsutoyo Co.,
Kawasaki, Japan) and measured with a micrometer in
close proximity to the muscle. The optimal length of
the muscle (Lo) was defined as the muscle length at
which twitch tension development was maximal, and
this Lo was maintained in the following measure-
ments.
The diaphragm force-frequency relationship was
assessed by sequentially stimulating muscles at 1, 10,
20, 30, 50, 70, 100 and 120 Hz, respectively. Each
stimulus train was applied for approximately 1 sec-
ond, and adjacent trains were applied at approxi-
mately 10-second intervals. The tensions of both mus-
cle strips were recorded by a hot-pen recorder
(RECTI-HORIZ-8K, San-ei Co., Tokyo, Japan). The
force-frequency curves obtained from the groups
studied were displayed as elicited tensions (Ncm2)
on the Y-axis and stimulating frequencies on the X-
axis.
Twitch contraction was elicited by a single pulse
stimulation (0.2-ms duration of pulses), and the trace
of the twitch contraction was recorded at high speed
(10 cmseconds). The twitch kinetics were assessed
by twitch tension (TT, Ncm2), contraction time (CT,
the time required to develop peak tension, millisec-
onds) and half relaxation time (HRT, the time re-
quired for peak tension to fall by 50%, milliseconds)
during a single muscle contraction. For the analysis
of contractile velocity of twitch contractions, TTCT
(slope during contraction time) and (TT2)HRT
(slope during half relaxation time) were calculated
from the curve of the twitch contraction trace. After
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Fig. 1 Changes in the force-frequency curves in the pro-
caterol inhalation group at 0 hours (open circle), 30 minutes 
(closed triangle), 1 hour (open triangle), 2 hours (closed 
square), and 4 hours (open square), respectively. ＊ p＜




























Table 1 Changes in Twitch Kinetics and Fatigue Indices in the Procaterol Inhalation Groups.
P 4 hP 2 hP 1 hP 30’P 0 h
0.037 ± 0.0030.036 ± 0.0040.038 ± 0.0040.044 ± 0.0040.037 ± 0.004TT (N/cm2)
0.027 ± 0.0010.026 ± 0.0020.025 ± 0.0020.028 ± 0.0010.027 ± 0.002CT (sec)
0.037 ± 0.0040.034 ± 0.0040.040 ± 0.0040.041 ± 0.0040.040 ± 0.004HRT (sec)
1.37 ± 0.101.35 ± 0.151.49 ± 0.131.53 ± 0.101.37 ± 0.12TT/CT (N/cm2/sec)
0.52 ± 0.040.53 ± 0.040.48 ± 0.040.54 ± 0.040.46 ± 0.03(TT/2)/HRT (N/cm2/sec)
TT denotes twitch tension, CT contraction time, HRT half relaxation time.
completion of this protocol, the muscle strip was re-
moved from the organ bath and weighed.
DATA ANALYSIS
The cross-sectional area of the strip was calculated by
dividing the muscle mass by the product of the strip
muscle length and muscle density (1.06 gcm3),12
and tension was calculated as force per unit area (N
cm2). Data obtained from both halves of the dia-
phragm in one animal were averaged; therefore, the
number of samples used was n = 5 (animals) per
treatmenttime point for force-frequency curves,
twitch kinetics and fatigability. The mean values of
tensions for each frequency of force-frequency
curves, twitch kinetics and fatigability were compared
by Student’s t -test. To compare the entire configura-
tion of each force-frequency curve at 0 and 4 hours
for each group, analysis of variance (ANOVA) with
Fisher’s protected least significant difference (PLSD)
post hoc test was performed, and parameters of twitch
kinetics were compared using two-way repeated-
measures ANOVA with Fisher’s PLSD post hoc test.
Data are presented as means ± SEM (standard error
of the mean). P -values < 0.05 were considered to indi-
cate significant differences.
RESULTS
CHANGES OF CONTRACTION PROPERTIES IN
THE INHALATION GROUPS
In the inhalation group, the tensions of force-
frequency curves at 30 minutes mostly shifted up-
ward, and the force-frequency curves at 1, 2, and 4
hours were located between 30 minutes and 0 hours.
There was a significant change only at 70 Hz for 30
minutes (p < 0.05), but not at frequencies of 1, 2, and
4 hours compared with those at 0 hours (Fig. 1). Be-
cause the shifts of force-frequency curves due to inha-
lation were small, there were no significant differ-
ences in TT, CT, and HRT at each inhalation time
compared with those at 0 hours. Likewise, there were
no significant differences in TTCT and (TT2)HRT
at each inhalation time compared with those at 0
hours (Table 1).
CHANGES OF CONTRACTION PROPERTIES IN
THE ENDOTOXIN AND PROCATEROL INHALA-
TION PLUS ENDOTOXIN GROUPS
In the endotoxin injection only group, the force-
frequency curves shifted downward gradually from 0
hours (0.135 ± 0.004 Ncm2 as a peak) to 4 hours
(0.096 ± 0.006 Ncm2 as a peak) (Fig. 2A). There
were significant decreases at 100, and 120 Hz at 2
hours (each p < 0.05), and at 20 (p < 0.05), 30 (p<
0.01), 50, 70, 100, and 120 Hz (each p < 0.001), re-
spectively, at 4 hours compared with those immedi-
ately after endotoxin intraperitoneal injection (0
hours). This shows that the intraperitoneal admini-
stration of endotoxin deteriorated diaphragm muscle
contraction in the 4-hour follow-up period. On the
other hand, in the procaterol inhalation plus endo-
toxin administration group, the force-frequency
curves shifted upward from 0 hours (0.136 ± 0.006 N
cm2 as a peak) to 2 hours (0.163 ± 0.007 Ncm2 as a
peak), while those at 4 hours (0.147 ± 0.007 Ncm2 as
a peak) decreased to a level between those of 0 and 2
hours (Fig. 2B). The tensions of 50 (p < 0.05), 70 (p <
0.01), 100, and 120 Hz (each p < 0.05) each signifi-
cantly increased from the level at 0 hours.
There were no significant changes in TT, CT, and
HRT in the endotoxin injection only and procaterol in-
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Fig. 2 Changes in the force-frequency curves in the endotoxin (E) injection (A) and procaterol inhalation plus endotoxin (P
＋E) injection (B) groups at 0 hours (open circle), 2 hours (open triangle), and 4 hours (closed circle), respectively. ＊p＜























































P ＋ E 0 h
P ＋ E 2 h
P ＋ E 4 h
Table 2 Changes of Twitch Kinetics and Fatigue Indices in the Endotoxin Injection and Procaterol Inhalation plus Endotoxin 
Groups.
P＋E 4 hP＋E 2 hP＋E 0 hE 4 hE 2 hE 0 h
0.035 ± 0.0030.038 ± 0.003 0.033 ± 0.0020.020 ± 0.0020.029 ± 0.0030.024 ± 0.002TT (N/cm2)
0.029 ± 0.0010.028 ± 0.001 0.031 ± 0.0020.031 ± 0.0010.030 ± 0.0020.030 ± 0.001CT (sec)
0.042 ± 0.0040.038 ± 0.002 0.049 ± 0.0050.037 ± 0.0030.042 ± 0.0050.039 ± 0.003HRT (sec)
1.17 ± 0.091.36 ± 0.13 1.07 ± 0.070.67 ± 0.070.92 ± 0.080.83 ± 0.06TT/CT (N/cm2/sec)
0.42 ± 0.02 0.51 ± 0.05† †0.35 ± 0.030.30 ± 0.03 0.35 ± 0.03＊0.32 ± 0.02(TT/2)/HRT (N/cm2/sec)
TT denotes twitch tension, CT contraction time, HRT half relaxation time.
Significant diferences compared with E 0 h: ＊p＜0.05, and that compared with P＋E 0 h: †† p＜0.01.
halation plus endotoxin administration groups. The
(TT2)HRT in the endotoxin only group was signifi-
cantly increased at E 2 hours (p < 0.05), compared
with that of E 0 hours, and that of the procaterol inha-
lation plus endotoxin injection group was significantly
increased at P + E 2 hours (p < 0.01) compared with
that of P + E 0 hours (Table 2). These data indicate
that procaterol increases relaxation speeds more than
endotoxin only does, especially at 2 hours after pro-
caterol inhalation.
CHANGES OF CONTRACTION PROPERTES IN
THE INCUBATION GROUPS
We performed an incubation study of procaterol in vi-
tro to confirm the effects of procaterol observed in
the in vivo study detailed above. At first, in the nor-
mal diaphragm groups, the force-frequency curves
shifted upward in a manner dependent on the pro-
caterol concentration of 10−7, 10−6, and 10−5 M
(Fig. 3A), respectively. With 10−5 M of procaterol (P
10−5 M), there were significant increases at 1 (p <
0.05), 10 (p < 0.01), 30 (p < 0.05), 50 (p < 0.01), 70,
100, and 120 Hz (each p < 0.001), respectively, com-
pared with each value of buffer only (B). Thus, the
entire force-frequency curve at 10−5 M (0.189 ± 0.007
Ncm2 as a peak) was significantly higher than that
of 0 M (0.145 ± 0.005 Ncm2 as a peak) (p < 0.001).
Secondly, in the endotoxin plus incubation with pro-
caterol groups, the force-frequency curves shifted up-
ward in a dose-dependent manner (Fig. 3B). With 10−
5 M of procaterol (E, P 10−5 M), there were significant
increases at 1, and 20 Hz (each p < 0.01), 30 (p <
0.05), 50, 70, 100, and 120 Hz (each p < 0.01), respec-
tively, compared with each value for the buffer only
(E, B), and with 10−6 M of procaterol (E, P 10−6 M),
there were significant increases at 20 (p < 0.01), 30
(p < 0.01), 50, 70, 100, and 120 Hz (each p < 0.001), re-
spectively, compared with the respective values of the
buffer only. Again, the entire force-frequency curve at
10−5 M (0.170 ± 0.010 Ncm2 as a peak) was signifi-
cantly higher than that for 0 M (0.127 ± 0.004 Ncm2
as a peak) (p < 0.001).
The TT of both normal muscle (p < 0.05) and endo-
toxin damaged muscles (p < 0.01) incubated in a 10−5
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Fig. 3 Changes in the force-frequency curves in the procaterol incubation with normal diaphragm (A), and procaterol incu-
bation with endotoxin administered diaphragm (B) groups at bufer only (B or E, B; open circle), procaterol 10 －5 M (P or E, 
P 10 －5 M; open triangle), 10 －6 M (P or E, P 10 －6 M; open square), and 10 －7 M (P or E, P 10 －7 M; closed square), 


















E, P 10－5 M
E, P 10－6 M



















































Table 3 Changes of Twitch Kinetics and Fatigue Indices in the Incubation Groups.
P 10 －7 MP 10 －6 MP 10 －5 MB 0 M
0.050 ± 0.0040.045 ± 0.006 0.056 ± 0.003＊0.042 ± 0.002TT (N/cm2)
 0.042 ± 0.004＊ ＊0.032 ± 0.0020.032 ± 0.0010.032 ± 0.001CT (sec)
 0.063 ± 0.006＊0.044 ± 0.0060.046 ± 0.0060.044 ± 0.003HRT (sec)
1.24 ± 0.161.39 ± 0.13 1.74 ± 0.11＊1.31 ± 0.06TT/CT (N/cm2/sec)
0.41 ± 0.030.51 ± 0.03 0.64 ± 0.06＊ ＊0.48 ± 0.03(TT/2)/HRT (N/cm2/sec)
E, P 10 －7 ME, P 10 －6 ME, P 10 －5 ME, B 0 M
0.043 ± 0.0060.047 ± 0.005 0.048 ± 0.001†0.038 ± 0.002TT (N/cm2)
0.041 ± 0.0010.035 ± 0.0020.035 ± 0.0010.037 ± 0.002CT (sec)
0.058 ± 0.0030.045 ± 0.0070.057 ± 0.0110.055 ± 0.007HRT (sec)
1.05 ± 0.12 1.34 ± 0.08† 1.38 ± 0.02††1.03 ± 0.05TT/CT (N/cm2/sec)
0.37 ± 0.03 0.53 ± 0.02†0.47 ± 0.070.36 ± 0.03(TT/2)/HRT (N/cm2/sec)
TT denotes twitch tension, CT contraction time, HRT half relaxation time.
Significant diferences compared with B 0 M: ＊p＜0.05; ＊＊p＜0.01, and that compared with E, B 0 M: † p＜0.05; †† p＜0.01.
M concentration of procaterol increased significantly.
Both CT and HRT increased at 10−7 M (p < 0.01 and
p < 0.05, each) compared to those of B 0 M. Regard-
ing TTCT, there were significant increases at 10−5 M
(p < 0.05), and endotoxin damaged muscle plus pro-
caterol incubation at 10−5 and 10−6 M (each p < 0.01,
p < 0.05), respectively. Similarly, as for (TT2)HRT,
there were significant increases at 10−5 M (p < 0.01)
in comparison with that of B 0M, and for endotoxin
damaged muscle plus procaterol incubation at 10−6 M
(p < 0.05) (Table 3).
DISCUSSION
In the present study, the inhalation of procaterol itself
initially shifted force-frequency curves upward at 30
minutes after inhalation only at 70 Hz. Subsequently,
however, there were no significant changes in the
force-frequency curves. Secondly, in the endotoxin in-
jection group, the force-frequency curves shifted
downward in a time-dependent manner. On the other
hand, in the procaterol inhalation plus endotoxin in-
jection group, the force-frequency curves mostly
shifted upward at 2 hours and decreased at 4 hours.
Thirdly, in the incubation groups, procaterol shifted
force-frequency curves upward in a dose-dependent
manner in the normal diaphragm muscles. Even
when using endotoxin damaged muscle incubated in
procaterol, the force-frequency curves similarly
shifted upward. From these results, procaterol can be
considered to have a direct inotropic effect on the
skeletal muscles such as diaphragm muscles, and,
this finding in itself seems very important clinically
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and pharmacologically.
It has been reported that salbutamol has inotropic
effects on rat diaphragm contractility and that these
effects are potentiated by foreshortening.13 In addi-
tion, it has been reported that albuterol (salbutamol)
inhalation enhances respiratory muscle output in pa-
tients with COPD primarily by improving the length-
tension relationship of the diaphragm rather than by
improving its contractility14 and that albuterol re-
duces dynamic hyperinflation during exercise in pa-
tients with COPD.15 Whether or not procaterol acts
on the skeletal muscles such as diaphragm muscles
has not been previously examined. Our results indi-
cate that procaterol has inotropic effects on dia-
phragm muscles in mice and that these effects may
be additive with primary bronchodilator activity. Con-
cerning the relatively slight augmentation of force-
frequency curves by procaterol inhalation in vivo, we
speculate that this is due to parasympathetic activities
which might antagonize the effects of β2-agonists.
Even when we administered β2-agonists such as pro-
caterol, therefore, the force-frequency shift was de-
pressed compared with that in the in vitro study.
A previous study found that adrenaline acts directly
through cyclic AMP to produce an increase in twitch
tension.16 The force potentiating effect is considered
to occur via binding to membrane-bound β-receptors,
and adrenergic stimulation exerts its effect via a
stimulatory G-protein which activates adenylate cyc-
lase resulting in formation of cyclic adenosine mono-
phosphate (cAMP), and cAMP acts as a second mes-
senger and activates protein kinases which catalyze
protein phosphorylation.17 It has been also reported
that force is potentiated following β-adrenoceptor acti-
vation by a cyclic AMP-dependent phosphorylation of
Ca2+ release channels to facilitate sarcoplasmic reticu-
lum (SR) calcium release during titanic stimulation.18
From these previous reports, it may be concluded
that the augmented force-frequency curves in our in
vitro study might have been exerted via cAMP incre-
ments by procaterol dose-dependent administration.
Endotoxin, a cell wall component of all gram-
negative bacteria, is well known to be responsible for
a large part of the toxic manifestations associated
with infections by such bacteria and for a generalized
and potentially lethal inflammatory reaction, known
as the generalized Schwartzman reaction.19 In par-
ticular, IFN-γ is more important in the pathogenesis
of the generalized Schwartzman reaction, specifically
by its interaction with other cytokines, namely, THF-
α, IL-6, and IFN-α andor -β. Based on the findings
by the present authors showing that TNF-α mRNA is
expressed in diaphragm muscle cells after endotoxin
administration,8 we also speculate that TNF-α and
NO may contribute to endotoxin induced diaphragm
muscle contractile deterioration. We also previously
reported that IL-109 and IL-1310 have protective ef-
fects against endotoxin induced diaphragm muscle
deterioration due to blockage of NO production.
From these previous studies, the results of the pre-
sent experiment might suggest possibilities that pro-
caterol inhibits cytokines such as TNF-α and NO pro-
duction, and that procaterol directly affects muscle
contractility, even if a muscle suffers cellular damage.
Recently, it has been reported that isoproterenol
(which has both β1 and β2-agonist activity) increased
diaphragmatic contractility with an increment of cy-
clic AMP (cAMP). However, in the same study using
cecal ligation and perforation (CLP), measured at 16
hours after the operation, diaphragmatic contractility
was still depressed compared with that of the sham-
operated animals in the septic peritonitis model of
Wister rats.11 It was speculated that there might be a
diaphragm muscle injury andor dysfunction in the
adenylate cyclase system elicited by oxygen-derived
free radicals. On the other hand, we have found that
in diaphragm muscles subjected to endotoxin injec-
tion, force-frequency curves decreased, but then in-
creased with the incubation of procaterol in a dose-
dependent manner at 4 hours. There are several dif-
ferences in the experimental designs, namely with re-
gard to the animals (rats vs. mice), the surgery (CLP)
or endotoxin intraperitoneal injection, and the waiting
times (16 or 4 hours). We suggest that diaphragm
muscle is probably still able to respond to β2-agonists
such as procaterol in the early period after endotoxin
injection, and thus force-frequency curves recover in
the manner revealed by the present study. Even
though the cellular damage by free-radicals andor
cytokines might begin relatively early after injection
of endotoxin observed in our previous data, in the
early stage of endotoxin injection β-adrenoreceptors
are not fully damaged and are thus able to stimulate
G-protein, resulting in activation of adenylate cyclase
and the consequent formation of cyclic adenine
monophosphate (cAMP).
β2-agonists induce inhibition of airway smooth-
muscle cell proliferation and inflammatory mediator
release, as well as nonsmooth-muscle effects, such as
stimulation of mucociliary transport, cytoprotection of
the respiratory mucosa, and attenuation of neutrophil
recruitment and activation.20 It has also been re-
ported that procaterol has inhibitory effects on
antigen-induced airway microvascular leakage and
bronchoconstriction,21 that the combination of theo-
phylline and procaterol has inhibitory effects on the
function of eosinophil,22 and that procaterol inhibits
IL-1β- and TNF-α-mediated epithelial cell eosinophil
chemotactic activity.23 From these reports, it seems
that procaterol has an inhibitory effect on cytokine
production in eosinophils, and we speculated that
there are similar effects in diaphragm muscle tissue.
Previous finding coupled with our results indicate
that procaterol affects not only the bronchial smooth
muscles and immunological activities, but also the
diaphragm skeletal muscles.
Effects of Procaterol on Diaphragm Muscle
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In conclusion, procaterol has an inotropic effect on
the diaphragmatic muscles taken from normal ani-
mals as well as on diaphragm muscles in a septic ani-
mal model. Even if the upward shift of the force-
frequency curves is relatively small, it may be said
that procaterol inhalation results in increases in the
force-frequency curves. As a clinical application of the
experiment, it is suggested that procaterol, by in-
creasing diaphragm contractility, may relieve dysp-
nea and thus improve quality of life in patients with
respiratory diseases.
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